Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
inhaler
Pharma
AZ pads data package for Airsupra in patients with milder asthma
AstraZeneca is padding the case for Airsupra with new data showing it can cut the risk of asthma exacerbations regardless of disease severity.
Fraiser Kansteiner
Oct 7, 2024 2:40pm
FTC launches investigation into Teva's inhaler patents: report
Jul 2, 2024 10:02am
GSK plays defense on call to pull popular children's asthma med
May 3, 2024 10:19am
FTC blasts Teva for 'improper' inhaler patents
Mar 25, 2024 10:04am
GSK sets $35 out-of-pocket price cap for its inhalers in the US
Mar 21, 2024 11:45am
AstraZeneca enlists Walter the Dino to paint rivals as outdated
Mar 21, 2024 7:12am